Evolution of specific RNA aptamers via SELEX targeting recombinant human CD36 protein: A candidate therapeutic target in severe malaria
Objective: To isolate and characterize RNA aptamers that are specific to human CD36 protein using systematic evolution of ligands by exponential enrichment (SELEX) technology to identify candidates for adjunct therapy to reverse the binding of Plasmodium-infected erythrocytes. Methods: RNA aptamers...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
| Series: | Asian Pacific Journal of Tropical Biomedicine |
| Subjects: | |
| Online Access: | http://www.apjtb.org/article.asp?issn=2221-1691;year=2020;volume=10;issue=1;spage=23;epage=32;aulast=Nik |
| _version_ | 1818574905274269696 |
|---|---|
| author | Nik Abdul Aziz Nik Kamarudin Judy Nur Aisha Sat Nur Fatihah Mohd Zaidi Khairul Mohd Fadzli Mustaffa |
| author_facet | Nik Abdul Aziz Nik Kamarudin Judy Nur Aisha Sat Nur Fatihah Mohd Zaidi Khairul Mohd Fadzli Mustaffa |
| author_sort | Nik Abdul Aziz Nik Kamarudin |
| collection | DOAJ |
| description | Objective: To isolate and characterize RNA aptamers that are specific to human CD36 protein using systematic evolution of ligands by exponential enrichment (SELEX) technology to identify candidates for adjunct therapy to reverse the binding of Plasmodium-infected erythrocytes.
Methods: RNA aptamers were isolated using nitrocellulose membrane-based SELEX and binding analysis was screened using an electrophoretic mobility shift assay and enzyme-linked oligonucleotide assay.
Results: Thirteen cycles of nitrocellulose membrane-based SELEX yielded three aptamers (RC60, RC25, RC04) exhibiting high binding against CD36 protein as shown on electrophoretic mobility shift assay. The sequence analysis revealed a G-quadruplex sequence within all the isolated aptamers that might contribute to aptamer binding and thermodynamic stability. The specificity assay further showed that RC60 and RC25 were highly specific to CD36. The competitive inhibition assay demonstrated that RC60 and RC25 shared a similar binding epitope recognized by mAb FA6-152, a specific monoclonal antibody against CD36.
Conclusions: RC60 and RC25 are promising candidates as anti-cytoadherence for severe malaria adjunct therapy. |
| first_indexed | 2024-12-15T00:32:34Z |
| format | Article |
| id | doaj.art-f075fded7922444b810e9806ca8ab698 |
| institution | Directory Open Access Journal |
| issn | 2588-9222 |
| language | English |
| last_indexed | 2024-12-15T00:32:34Z |
| publishDate | 2020-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Asian Pacific Journal of Tropical Biomedicine |
| spelling | doaj.art-f075fded7922444b810e9806ca8ab6982022-12-21T22:41:56ZengWolters Kluwer Medknow PublicationsAsian Pacific Journal of Tropical Biomedicine2588-92222020-01-01101233210.4103/2221-1691.273091Evolution of specific RNA aptamers via SELEX targeting recombinant human CD36 protein: A candidate therapeutic target in severe malariaNik Abdul Aziz Nik KamarudinJudy Nur Aisha SatNur Fatihah Mohd ZaidiKhairul Mohd Fadzli MustaffaObjective: To isolate and characterize RNA aptamers that are specific to human CD36 protein using systematic evolution of ligands by exponential enrichment (SELEX) technology to identify candidates for adjunct therapy to reverse the binding of Plasmodium-infected erythrocytes. Methods: RNA aptamers were isolated using nitrocellulose membrane-based SELEX and binding analysis was screened using an electrophoretic mobility shift assay and enzyme-linked oligonucleotide assay. Results: Thirteen cycles of nitrocellulose membrane-based SELEX yielded three aptamers (RC60, RC25, RC04) exhibiting high binding against CD36 protein as shown on electrophoretic mobility shift assay. The sequence analysis revealed a G-quadruplex sequence within all the isolated aptamers that might contribute to aptamer binding and thermodynamic stability. The specificity assay further showed that RC60 and RC25 were highly specific to CD36. The competitive inhibition assay demonstrated that RC60 and RC25 shared a similar binding epitope recognized by mAb FA6-152, a specific monoclonal antibody against CD36. Conclusions: RC60 and RC25 are promising candidates as anti-cytoadherence for severe malaria adjunct therapy.http://www.apjtb.org/article.asp?issn=2221-1691;year=2020;volume=10;issue=1;spage=23;epage=32;aulast=Nikrna aptamers; selex; cd36 protein; severe malaria; adjunct therapy; cytoadherence |
| spellingShingle | Nik Abdul Aziz Nik Kamarudin Judy Nur Aisha Sat Nur Fatihah Mohd Zaidi Khairul Mohd Fadzli Mustaffa Evolution of specific RNA aptamers via SELEX targeting recombinant human CD36 protein: A candidate therapeutic target in severe malaria Asian Pacific Journal of Tropical Biomedicine rna aptamers; selex; cd36 protein; severe malaria; adjunct therapy; cytoadherence |
| title | Evolution of specific RNA aptamers via SELEX targeting recombinant human CD36 protein: A candidate therapeutic target in severe malaria |
| title_full | Evolution of specific RNA aptamers via SELEX targeting recombinant human CD36 protein: A candidate therapeutic target in severe malaria |
| title_fullStr | Evolution of specific RNA aptamers via SELEX targeting recombinant human CD36 protein: A candidate therapeutic target in severe malaria |
| title_full_unstemmed | Evolution of specific RNA aptamers via SELEX targeting recombinant human CD36 protein: A candidate therapeutic target in severe malaria |
| title_short | Evolution of specific RNA aptamers via SELEX targeting recombinant human CD36 protein: A candidate therapeutic target in severe malaria |
| title_sort | evolution of specific rna aptamers via selex targeting recombinant human cd36 protein a candidate therapeutic target in severe malaria |
| topic | rna aptamers; selex; cd36 protein; severe malaria; adjunct therapy; cytoadherence |
| url | http://www.apjtb.org/article.asp?issn=2221-1691;year=2020;volume=10;issue=1;spage=23;epage=32;aulast=Nik |
| work_keys_str_mv | AT nikabdulaziznikkamarudin evolutionofspecificrnaaptamersviaselextargetingrecombinanthumancd36proteinacandidatetherapeutictargetinseveremalaria AT judynuraishasat evolutionofspecificrnaaptamersviaselextargetingrecombinanthumancd36proteinacandidatetherapeutictargetinseveremalaria AT nurfatihahmohdzaidi evolutionofspecificrnaaptamersviaselextargetingrecombinanthumancd36proteinacandidatetherapeutictargetinseveremalaria AT khairulmohdfadzlimustaffa evolutionofspecificrnaaptamersviaselextargetingrecombinanthumancd36proteinacandidatetherapeutictargetinseveremalaria |